DGXQuest Diagnostics
$255.60+47% 1Y
$255.60
$171.9552 weeks$255.60
Latest close: a new 52-week highNov 6, 2026what changed →
Growth
Is DGX growing?
Quest Diagnostics's revenue has grown 8.4% a year over three years, and grown 1.4% a year over five, with earnings per share compounding at 14%.
+8.4%
Revenue growth, 3-year annual rate · Diagnostics & Research median +9.4% · compounded from trailing twelve-month revenue
- Revenue growth, 5-year rate
- +1.4%
Revenue growth, 5-year rate · +8.4% over three · the three-year rate is above the five-year rate
- Earnings per share, 3-year rate
- +14%
Earnings per share, 3-year rate · revenue +8.4% · earnings per share grew faster than revenue
- Years of annual history on file
- 19
Years of annual history on file · FY2007 to FY2025, as filed
Details›
- Revenue FY2021
- $10.8B
- Revenue FY2022
- $9.88B
- Revenue FY2023
- $9.25B
- Revenue FY2024
- $9.87B
- Revenue FY2025
- $11.0B
Annual income statements as filed with the SEC.
Where the revenue comes from
16 quarters, Sep 2022 to Jun 2026Diagnostic Information Services Business, quarter to Jun 2026from $2.42B in Sep 2022$2.98B
Diagnostic Information Services Business$2.98B
All Other$65.0M
Operating metrics
From earnings releases, Q3 2021 to Q3 2026
Requisition volume growth, Q3 2026+2.0 points on a year ago14.5%
+2.0 points on a year ago
Revenue per requisition growth−4.2%
Q3 2026, −5.0 points on a year ago
Requisition volume growth, Q3 2026: 14.5%
Requisition volume14.5%12.9%
Source: Q3 2026 earnings release, filed Oct 22, 2026Diagnostics & Research
The closest names by size in the same industry